Molecular-cellular mechanisms of pulmonary fibrosis and spontaneous pneumothorax

1. Akopov A.L., Varlamov V.V. Spontaneous pneumothorax (surgical aspects). Ed. N.A. Yaitsky. Saint-Petersburg, 2009. 20 p. (in Russian)

2. Boksha V.G. Violation of respiratory function in bronchopulmonary and cardiovascular diseases. Kiev: Zdorov'ya, 1991. 200 p. (in Russian)

3. Kaminskaya G.O. Nitric oxide – its biological role and involvement in the pathology of the respiratory system // Problemy tuberkulyoza i bolezney lyogkikh. 2004. (6). 3–11. (in Russian)

4. Klimanov L.A., Soodaeva S.K., Lisitsa A.V., Chuchalin A.G. Changing the metabolism of nitric oxide in hay fever and asthma // Pul'monologiya. 2006. (4). 30–33. (in Russian)

5. Pismennyi A.K., Korymasov E.A., Fedorin I.M. Spontaneous pneumothorax. Optimization of surgical approach. Samara: Perspectiva, 2002. 164 p. (in Russian)

6. Popov E.V. Endothelins: origin, physiological effects and possible role in disease // Tuberculosis and lung diseases. 2010. (5). 3–13. (in Russian)

7. Postnikova L.B., Kubysheva N.I., Mindubaev R.Z. et al. Features of the content of endothelin-1 and endobronchial concentration of nitric oxide metabolites in patients with chronic obstructive pulmonary disease // Pulmonologiya. 2010. (3). 108–112. (in Russian)

8. Roytberg G.E., Strutynsky A.V. Internal medicine. Respiratory system. Moscow: Binom, 2005. 464 p. (in Russian)

9. Titov V.N. Diagnostic value of endothelin-related vaodilatation. Functional unity of endothelin, nitric oxide formation and function in the phylogenesis // Klinicheskaya laboratornaya diagnostika. 2009. (2). 3–16. (in Russian)

10. Shevchenko O.P. Homocysteine and its role in clinical practice // Klinicheskaya laboratornaya diagnostika. 2008. (11). 25–34. (in Russian)

11. Bense L., Eklund G., Odont D. et al. Smoking and the increased risk of contracting pneumothorax // Chest. 1987. 92. 1009–1012.

12. Guo Y., Xie C., Rodriguez R.M., Light R.W. Factors related to recurrence of spontaneous pneumo­thorax // Respirology. 2005. 10. 378–384.

13. Ferguson H.E., Kulkarni A., Lehmann G.M. et al. Electrophilic peroxisome proliferator–activated receptor-γ ligands have potent antifibrotic effects in human lung fibroblasts // Am. J. Respir. Cell Mol. Biol. 2009. 41. (6). 722–730.

14. Sadikot R.T., Greene T., Meadows K., Arnold A.G. Recurrence of primary spontaneous pneumothorax // Thorax. 1997. 52. 805–809.

15. Kolb M., Bonniaud P., Galt T. et al. Differences in the fibrogenic response after transfer of active transforming growth factor-β1 gene to lungs of «fibro­sis-prone» and «fibrosis-resistant» mouse strains // Am. J. Respir. Cell Mol. Biol. 2002. 27. 141–150.

16. MacDuff A., Arnold A., Harvey J. Management of spontaneous pneumothorax: British Thoracic Society pleural disease guideline // Thorax. 2010. 65. ii18–ii31.

17. Meltzer E.B., Noble P.W. Idiopathic pulmonary fibrosis // Orphanet J. Rare Dis. 2008. 3. 8.

18. Phan S.H. The myofibroblast in pulmonary fibrosis // Chest. 2002. 122. (6, Suppl.). 286S–289S.

19. Sime P.J., Xing Z., Graham F.L. et al. Adenovector-mediated gene transfer of active transfor­ming growth factor-beta1 induces prolonged severe fibrosis in rat lung // J. Clin. Invest. 1997. 100. 768–776.

20. Gu H., Mickler E.A., Cummings O.W. et al. Crosstalk between TGF-β1 and complement activation augments epithelial injury in pulmonary fibrosis // FASEB J. 2014. doi: 10.1096/fj.13-247650.

21. Wan Y.Y., Tian G.Y., Guo H.S. et al. Endostatin, an angiogenesis inhibitor, ameliorates bleomycin-induced pulmonary fibrosis in rats // Respir. Res. 2013. 14. (1). :56.